Increased vascular permeability in the bone marrow microenvironment contributes to disease progression and drug response in acute myeloid leukemia
More about Open Access at the CrickAuthors list
Diana Passaro Alessandro Di Tullio Ander Abarrategi Kevin Rouault-Pierre Katie Foster Linda Ariza-Mcnaughton Beatriz Montaner Probir Chakravarty Leena Bhaw Giovanni Diana François Lassailly John Gribben Dominique BonnetAbstract
The biological and clinical behaviors of hematological malignancies can be influenced by the active crosstalk with an altered bone marrow (BM) microenvironment. In the present study, we provide a detailed picture of the BM vasculature in acute myeloid leukemia using intravital two-photon microscopy. We found several abnormalities in the vascular architecture and function in patient-derived xenografts (PDX), such as vascular leakiness and increased hypoxia. Transcriptomic analysis in endothelial cells identified nitric oxide (NO) as major mediator of this phenotype in PDX and in patient-derived biopsies. Moreover, induction chemotherapy failing to restore normal vasculature was associated with a poor prognosis. Inhibition of NO production reduced vascular permeability, preserved normal hematopoietic stem cell function, and improved treatment response in PDX.
Journal details
Journal Cancer Cell
Volume 32
Issue number 3
Pages 324-341.e6
Available online
Publication date
Full text links
Publisher website (DOI) 10.1016/j.ccell.2017.08.001
Figshare View on figshare
Europe PubMed Central 28870739
Pubmed 28870739
Keywords
Related topics
Type of publication